Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob S Brenner

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Pulmonary Circulation|December 21, 2017
The new frontiers of the targeted interventions in the pulmonary vasculature: precision and safety (2017 Grover Conference Series)Jacob S Brenner, Raisa Yu Kiseleva, Patrick M Glassman, et al.
Scientific Reports|January 31, 2018
Molecular engineering of antibodies for site-specific covalent conjugation using CRISPR/Cas9Makan Khoshnejad, Jacob S Brenner, William Motley, et al.
Nano Letters|April 10, 2024
Combination of Physicochemical Tropism and Affinity Moiety Targeting of Lipid Nanoparticles Enhances Organ TargetingMarco E Zamora, Serena Omo-Lamai, Manthan N Patel, et al.
Mabs|December 16, 2020
Monoclonal antibody 2C5 specifically targets neutrophil extracellular trapsLivia P Mendes, Kobra Rostamizadeh, Kandace Gollomp, et al.
ATS Scholar|April 19, 2021
COVID-19 and the Early-Career Physician-Scientist. Fostering Resilience beyond the PandemicCorrine R Kliment, Ian J Barbash, Jacob S Brenner, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 19, 2022
Imatinib alleviates lung injury and prolongs survival in ventilated ratsYi Xin, Maurizio Cereda, Nadir Yehya, et al.
Life Science Alliance|August 12, 2024
Neutrophil-avid nanocarrier uptake by STAT3 dominant-negative hyper-IgE syndrome patient neutrophilsKathryn M Rubey, Alexandra Freeman, Alexander R Mukhitov, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 16, 2019
Combining vascular targeting and the local first pass provides 100-fold higher uptake of ICAM-1-targeted vs untargeted nanocarriers in the inflamed brainOscar A Marcos-Contreras, Jacob S Brenner, Raisa Y Kiseleva, et al.
Advanced Nanobiomed Research|June 2, 2023
Mechanisms by Which Liposomes Improve Inhaled Drug Delivery for Alveolar DiseasesLaura T Ferguson, Xiaonan Ma, Jacob W Myerson, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 12, 2024
Conjugation Chemistry Markedly Impacts Toxicity and Biodistribution of Targeted Nanoparticles, Mediated by Complement ActivationMichael H Zaleski, Liam S Chase, Elizabeth D Hood, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Pulmonary Circulation|December 21, 2017
The new frontiers of the targeted interventions in the pulmonary vasculature: precision and safety (2017 Grover Conference Series)Jacob S Brenner, Raisa Yu Kiseleva, Patrick M Glassman, et al.
Scientific Reports|January 31, 2018
Molecular engineering of antibodies for site-specific covalent conjugation using CRISPR/Cas9Makan Khoshnejad, Jacob S Brenner, William Motley, et al.
Nano Letters|April 10, 2024
Combination of Physicochemical Tropism and Affinity Moiety Targeting of Lipid Nanoparticles Enhances Organ TargetingMarco E Zamora, Serena Omo-Lamai, Manthan N Patel, et al.
Mabs|December 16, 2020
Monoclonal antibody 2C5 specifically targets neutrophil extracellular trapsLivia P Mendes, Kobra Rostamizadeh, Kandace Gollomp, et al.
ATS Scholar|April 19, 2021
COVID-19 and the Early-Career Physician-Scientist. Fostering Resilience beyond the PandemicCorrine R Kliment, Ian J Barbash, Jacob S Brenner, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 19, 2022
Imatinib alleviates lung injury and prolongs survival in ventilated ratsYi Xin, Maurizio Cereda, Nadir Yehya, et al.
Life Science Alliance|August 12, 2024
Neutrophil-avid nanocarrier uptake by STAT3 dominant-negative hyper-IgE syndrome patient neutrophilsKathryn M Rubey, Alexandra Freeman, Alexander R Mukhitov, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 16, 2019
Combining vascular targeting and the local first pass provides 100-fold higher uptake of ICAM-1-targeted vs untargeted nanocarriers in the inflamed brainOscar A Marcos-Contreras, Jacob S Brenner, Raisa Y Kiseleva, et al.
Advanced Nanobiomed Research|June 2, 2023
Mechanisms by Which Liposomes Improve Inhaled Drug Delivery for Alveolar DiseasesLaura T Ferguson, Xiaonan Ma, Jacob W Myerson, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 12, 2024
Conjugation Chemistry Markedly Impacts Toxicity and Biodistribution of Targeted Nanoparticles, Mediated by Complement ActivationMichael H Zaleski, Liam S Chase, Elizabeth D Hood, et al.
Pageof 8